These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1010 related articles for article (PubMed ID: 27852544)

  • 1. Investigation of IL23R, JAK2, and STAT3 gene polymorphisms and gene-gene interactions in Crohn's disease and ulcerative colitis in a Turkish population.
    Can G; Tezel A; Gürkan H; Tozkır H; Ünsal G; Soylu AR; Ümit HC
    Turk J Gastroenterol; 2016 Nov; 27(6):525-536. PubMed ID: 27852544
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Investigation of JAK2, STAT3 and CCR6 polymorphisms and their gene-gene interactions in inflammatory bowel disease.
    Polgar N; Csongei V; Szabo M; Zambo V; Melegh BI; Sumegi K; Nagy G; Tulassay Z; Melegh B
    Int J Immunogenet; 2012 Jun; 39(3):247-52. PubMed ID: 22269120
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tyrosine kinase-2 gene polymorphisms are associated with ulcerative colitis and Crohn's disease in Turkish Population.
    Can G; Tezel A; Gürkan H; Can H; Yılmaz B; Ünsal G; Soylu AR; Ümit HC
    Clin Res Hepatol Gastroenterol; 2015 Sep; 39(4):489-98. PubMed ID: 25744728
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic factors in chronic inflammation: single nucleotide polymorphisms in the STAT-JAK pathway, susceptibility to DNA damage and Crohn's disease in a New Zealand population.
    Ferguson LR; Han DY; Fraser AG; Huebner C; Lam WJ; Morgan AR; Duan H; Karunasinghe N
    Mutat Res; 2010 Aug; 690(1-2):108-15. PubMed ID: 20109474
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The JAK2 variant rs10758669 in Crohn's disease: altering the intestinal barrier as one mechanism of action.
    Prager M; Büttner J; Haas V; Baumgart DC; Sturm A; Zeitz M; Büning C
    Int J Colorectal Dis; 2012 May; 27(5):565-73. PubMed ID: 22065112
    [TBL] [Abstract][Full Text] [Related]  

  • 6. JAK2 rs10758669 polymorphisms and susceptibility to ulcerative colitis and Crohn's disease: a meta-analysis.
    Zhang JX; Song J; Wang J; Dong WG
    Inflammation; 2014 Jun; 37(3):793-800. PubMed ID: 24385239
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular prediction of disease risk and severity in a large Dutch Crohn's disease cohort.
    Weersma RK; Stokkers PC; van Bodegraven AA; van Hogezand RA; Verspaget HW; de Jong DJ; van der Woude CJ; Oldenburg B; Linskens RK; Festen EA; van der Steege G; Hommes DW; Crusius JB; Wijmenga C; Nolte IM; Dijkstra G;
    Gut; 2009 Mar; 58(3):388-95. PubMed ID: 18824555
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic association between IL23R rs11209026 and rs10889677 polymorphisms and risk of Crohn's disease and ulcerative colitis: evidence from 41 studies.
    Zhu Y; Jiang H; Chen Z; Lu B; Li J; Shen X
    Inflamm Res; 2020 Jan; 69(1):87-103. PubMed ID: 31728561
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epistasis between Toll-like receptor-9 polymorphisms and variants in NOD2 and IL23R modulates susceptibility to Crohn's disease.
    Török HP; Glas J; Endres I; Tonenchi L; Teshome MY; Wetzke M; Klein W; Lohse P; Ochsenkühn T; Folwaczny M; Göke B; Folwaczny C; Müller-Myhsok B; Brand S
    Am J Gastroenterol; 2009 Jul; 104(7):1723-33. PubMed ID: 19455129
    [TBL] [Abstract][Full Text] [Related]  

  • 10. rs1004819 is the main disease-associated IL23R variant in German Crohn's disease patients: combined analysis of IL23R, CARD15, and OCTN1/2 variants.
    Glas J; Seiderer J; Wetzke M; Konrad A; Török HP; Schmechel S; Tonenchi L; Grassl C; Dambacher J; Pfennig S; Maier K; Griga T; Klein W; Epplen JT; Schiemann U; Folwaczny C; Lohse P; Göke B; Ochsenkühn T; Müller-Myhsok B; Folwaczny M; Mussack T; Brand S
    PLoS One; 2007 Sep; 2(9):e819. PubMed ID: 17786191
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ATG16L1 and IL23R are associated with inflammatory bowel diseases but not with celiac disease in the Netherlands.
    Weersma RK; Zhernakova A; Nolte IM; Lefebvre C; Rioux JD; Mulder F; van Dullemen HM; Kleibeuker JH; Wijmenga C; Dijkstra G
    Am J Gastroenterol; 2008 Mar; 103(3):621-7. PubMed ID: 18047540
    [TBL] [Abstract][Full Text] [Related]  

  • 12. IL23R and IL12B polymorphisms in Spanish IBD patients: no evidence of interaction.
    Márquez A; Mendoza JL; Taxonera C; Díaz-Rubio M; De La Concha EG; Urcelay E; Martínez A
    Inflamm Bowel Dis; 2008 Sep; 14(9):1192-6. PubMed ID: 18383521
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetic determinants associated with early age of diagnosis of IBD.
    Connelly TM; Berg AS; Harris L; Brinton D; Deiling S; Koltun WA
    Dis Colon Rectum; 2015 Mar; 58(3):321-7. PubMed ID: 25664710
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Heterozygosity for IL23R p.Arg381Gln confers a protective effect not only against Crohn's disease but also ulcerative colitis.
    Büning C; Schmidt HH; Molnar T; De Jong DJ; Fiedler T; Bühner S; Sturm A; Baumgart DC; Nagy F; Lonovics J; Drenth JP; Landt O; Nickel R; Büttner J; Lochs H; Witt H
    Aliment Pharmacol Ther; 2007 Oct; 26(7):1025-33. PubMed ID: 17877509
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inherited determinants of Crohn's disease and ulcerative colitis phenotypes: a genetic association study.
    Cleynen I; Boucher G; Jostins L; Schumm LP; Zeissig S; Ahmad T; Andersen V; Andrews JM; Annese V; Brand S; Brant SR; Cho JH; Daly MJ; Dubinsky M; Duerr RH; Ferguson LR; Franke A; Gearry RB; Goyette P; Hakonarson H; Halfvarson J; Hov JR; Huang H; Kennedy NA; Kupcinskas L; Lawrance IC; Lee JC; Satsangi J; Schreiber S; Théâtre E; van der Meulen-de Jong AE; Weersma RK; Wilson DC; ; Parkes M; Vermeire S; Rioux JD; Mansfield J; Silverberg MS; Radford-Smith G; McGovern DP; Barrett JC; Lees CW
    Lancet; 2016 Jan; 387(10014):156-67. PubMed ID: 26490195
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of the interleukin-23 receptor gene variant rs11209026 with Crohn's disease in German children.
    Lacher M; Schroepf S; Helmbrecht J; Von Schweinitz D; Ballauff A; Koch I; Lohse P; Osterrieder S; Kappler R; Koletzko S
    Acta Paediatr; 2010 May; 99(5):727-733. PubMed ID: 20192940
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Contribution of the novel inflammatory bowel disease gene IL23R to disease susceptibility and phenotype.
    Cummings JR; Ahmad T; Geremia A; Beckly J; Cooney R; Hancock L; Pathan S; Guo C; Cardon LR; Jewell DP
    Inflamm Bowel Dis; 2007 Sep; 13(9):1063-8. PubMed ID: 17508420
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of the novel Th17 cytokine IL-17F in inflammatory bowel disease (IBD): upregulated colonic IL-17F expression in active Crohn's disease and analysis of the IL17F p.His161Arg polymorphism in IBD.
    Seiderer J; Elben I; Diegelmann J; Glas J; Stallhofer J; Tillack C; Pfennig S; Jürgens M; Schmechel S; Konrad A; Göke B; Ochsenkühn T; Müller-Myhsok B; Lohse P; Brand S
    Inflamm Bowel Dis; 2008 Apr; 14(4):437-45. PubMed ID: 18088064
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Associations between STAT3 rs744166 polymorphisms and susceptibility to ulcerative colitis and Crohn's disease: a meta-analysis.
    Zhang J; Wu J; Peng X; Song J; Wang J; Dong W
    PLoS One; 2014; 9(10):e109625. PubMed ID: 25286337
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The association of MYO9B gene in Italian patients with inflammatory bowel diseases.
    Latiano A; Palmieri O; Valvano MR; D'Incà R; Caprilli R; Cucchiara S; Sturniolo GC; Bossa F; Andriulli A; Annese V
    Aliment Pharmacol Ther; 2008 Feb; 27(3):241-8. PubMed ID: 17944996
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 51.